Interferon-Lambda 1 Inhibits Staphylococcus aureus Colonization in Human Primary Keratinocytes.

Area of Science:

• Immunology
• Dermatology
• Microbiology

Background:

• Atopic dermatitis (AD) is a prevalent inflammatory skin condition.
• Staphylococcus aureus (S. aureus) colonization is observed in approximately 70% of AD patients' skin lesions.
• Previous research indicates IFN-λ1 can inhibit S. aureus colonization in nasal mucosa.

Purpose of the Study:

• To investigate the effect of IFN-λ1 on S. aureus colonization in human keratinocytes.
• To elucidate the underlying molecular mechanisms of IFN-λ1's action in the context of AD.

Main Methods:

• Treatment of human keratinocytes with IFN-λ1.
• Analysis of mRNA expression for FLG, AMPs, and TSLP.
• Assessment of intracellular ROS levels and STAT1 phosphorylation.
• Evaluation of S. aureus colonization.
• Knockdown of IL-28R and use of NADPH oxidase inhibitor.

Main Results:

• IFN-λ1 increased FLG and antimicrobial peptide (AMP) mRNA expression.
• IFN-λ1 inhibited TSLP mRNA expression.
• IFN-λ1 increased intracellular ROS levels and decreased STAT1 phosphorylation.
• IFN-λ1 inhibited S. aureus colonization in human primary keratinocytes.
• The observed effects were dependent on IL-28R and NADPH oxidase, implicating the JAK-STAT1 pathway.

Conclusions:

• IFN-λ1 demonstrates an inhibitory effect on S. aureus colonization in human keratinocytes.
• The mechanism involves the JAK-STAT1 signaling pathway, increased ROS, and modulation of specific gene expressions.
• IFN-λ1 shows potential as a therapeutic agent for atopic dermatitis by targeting S. aureus colonization.